Get the Stockscreener App
155.25
0.29%
0.45
After Hours:
155.59
0.34
+0.22%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $155.25, with a volume of 915.78K.
It is up +0.29% in the last 24 hours and down -1.10% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
See More
Previous Close:
$154.80
Open:
$155.09
24h Volume:
915.78K
Relative Volume:
1.14
Market Cap:
$17.21B
Revenue:
$9.35B
Net Income/Loss:
$840.00M
P/E Ratio:
23.31
EPS:
6.66
Net Cash Flow:
$875.00M
1W Performance:
+0.82%
1M Performance:
-1.10%
6M Performance:
+16.63%
1Y Performance:
+27.40%
1-Day Range:
$153.55
$155.59
1-Week Range:
$151.89
$156.52
52-Week Range:
$119.59
$159.36
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Quest Diagnostics Inc. stock rises Monday, still underperforms market - MarketWatch
APG Asset Management N.V. Grows Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Zacks Research Analysts Raise Earnings Estimates for Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Canada Pension Plan Investment Board Has $2.97 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Escapes 401(k) Mismanagement Suit - Law360
Quest Diagnostics Amplifies Community Impact With Enhanced Corporate Giving Program and Record Employee Volunteerism in 2023 - StockTitan
Analysts Set Expectations for Quest Diagnostics Incorporated's Q2 2025 Earnings (NYSE:DGX) - MarketBeat
Quest Diagnostics Beats Would-be Class Suit Over 401(k) Funds - Bloomberg Law
Dark Forest Capital Management LP Acquires 11,456 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 - The Malaysian Reserve
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 - StockTitan
Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 - Yahoo Finance
Quest Diagnostics Stock Gains From New Offerings, Customer Wins - Yahoo Finance
Quest Diagnostics Stock Gains From New Offerings, Customer Wins - Zacks Investment Research
Point72 Hong Kong Ltd Acquires New Shares in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Potential Price Increase for Quest Diagnostics, Inc. (DGX) After Recent Insider Activity - Knox Daily
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance
Public Employees Retirement Association of Colorado Buys Shares of 11,180 Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Elevates Employee Well-Being - CSRwire.com
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? - Barchart
Hancock Whitney Corp Acquires 1,337 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - Defense World
100,000 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Integral Health Asset Management LLC - MarketBeat
Saliva Collection Devices Market Shifting Paradigms: How - openPR
Legacy Financial Advisors Inc. Grows Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - Defense World
XTX Topco Ltd Acquires 3,811 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Intech Investment Management LLC Has $10.53 Million Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Mercer Global Advisors Inc. ADV - Defense World
DGXQuest Diagnostics Inc. Latest Stock News & Market Updates - StockTitan
Quest Diagnostics Elevates Employee Well-Being With Relaunched HealthyQuest Program, Holistic Support Initiatives, and High Engagement in 2023 - StockTitan
Hsbc Holdings PLC Has $73.38 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Partners LLC Makes New Investment in UDR, Inc. (NYSE:UDR) - Defense World
Analysts Set Quest Diagnostics Incorporated (NYSE:DGX) PT at $154.33 - MarketBeat
Dynatrace, Inc. (NYSE:DT) Position Lowered by Quest Partners LLC - Defense World
Monkeypox (MPOX) Diagnostics Global Markets 2024-2028: New Strains Threaten New Outbreaks - GlobeNewswire Inc.
Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast - StockTitan
427 Shares in DICK’S Sporting Goods, Inc. (NYSE:DKS) Purchased by Quest Partners LLC - Defense World
Acadian Asset Management LLC Sells 6,431 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast - PR Newswire
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Those who invested in Quest Diagnostics (NYSE:DGX) five years ago are up 62% - Simply Wall St
Quest Diagnostics' Jim Davis on why the company is buying labs - Modern Healthcare
Texas Permanent School Fund Corp Sells 4,591 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics acquires Allina Health’s select lab assets - Medical Buyer
Quest Diagnostics Completes Acquisition of Allina Health Laboratory Assets - Marketscreener.com
Capital Wealth Planning LLC Buys Shares of 23,093 Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health – Company Announcement - Financial Times
Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health - StockTitan
Bokf Na Has $5.94 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy - Benzinga
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):